Dianthus Therapeutics Cash Flow Statement (2017-2025) | DNTH

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income (Quarter)
-92.73M-25.77M-24.72M-23.80M-28.05M-31.95M-29.85M-18.61M-10.05M-7.09M-11.74M-22.50M-15.07M-18.02M-65.00M-74.48M-24.34M-47.02M-50.57M-165.16M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M
Share-based Compensation (Quarter)
2.33M2.19M2.13M3.80M2.18M1.91M1.84M0.66M0.51M0.53M0.46M1.18M0.73M2.04M3.10M3.84M3.92M5.32M5.71M5.79M
Cash from Operations (Quarter)
-13.73M-16.77M-13.00M-14.07M-15.69M-19.74M-16.85M16.38M-8.85M-10.28M-4.73M-9.99M-11.85M-14.94M-14.53M-21.27M-27.44M-27.63M-23.89M-30.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.40M0.36M0.21M0.33M0.53M0.52M0.42M2.34M2.74M1.90M1.10M2.31M
Amortization of Deferred Charges (Quarter)
0.70M0.04M0.07M0.07M0.07M0.08M0.09M0.09M0.09M0.05M0.11M0.07M0.07M
Depreciation & Amortization (CF) (Quarter)
0.52M0.47M0.48M0.53M0.52M0.51M0.48M0.47M0.47M0.42M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
1.00M-0.96M4.96M
Change in Account Payables (Quarter)
1.37M-1.65M-0.35M0.12M1.15M1.40M-2.39M0.53M-0.34M-4.73M3.01M0.77M1.60M-2.99M3.25M5.65M2.28M-1.50M3.09M3.00M
Change in Accured Expenses (Quarter)
0.26M-0.58M0.98M0.19M-0.44M-0.86M-0.62M0.94M1.52M-3.34M-1.68M
Other Working Capital Changes (Quarter)
0.16M0.10M-0.42M1.48M-0.09M-0.13M-1.02M2.01M-0.23M-0.01M-0.00M-2.53M2.55M0.05M-0.05M8.16M1.91M-2.04M1.48M
Investing Activities
Capital Expenditures (Quarter)
0.21M0.01M0.11M1.13M0.01M0.03M0.13M-0.05M0.03M0.01M0.02M0.07M0.01M0.03M0.02M0.03M0.03M0.02M0.05M0.01M
Sales of Property, Plant and Equipment (Quarter)
1.51M0.57M
Change in Acquisitions & Divestments (Quarter)
20.00M7.50M30.00M17.50M35.00M2.00M22.00M21.89M15.90M18.00M15.00M8.00M19.00M85.00M82.14M59.60M78.57M
Cash from Investing Activities (Quarter)
-70.97M7.49M29.89M16.37M-10.32M-40.14M-0.13M-6.88M-12.66M18.13M21.86M-11.51M-8.24M-5.51M1.17M-259.36M-23.11M14.79M26.45M-201.28M
Financing Activities
Other financing activities (Quarter)
-1.79M0.42M-0.33M86.31M-0.05M0.01M0.27M0.05M0.30M0.48M0.03M0.57M-0.60M
Cash from Financing Activities (Quarter)
1.18M0.42M88.86M0.20M0.12M0.05M96.63M138.44M-4.87M217.85M-2.20M0.30M39.68M0.16M0.57M274.51M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
39.20M0.13M0.19M
Additional items
Change in Cash (Quarter)
-83.53M-8.86M105.75M2.50M-25.89M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M
Free Cash Flow (Quarter)
-13.95M-16.78M-13.11M-15.20M-15.71M-19.77M-16.98M16.42M-8.88M-10.30M-4.75M-10.06M-11.86M-14.97M-14.54M-21.29M-27.48M-27.65M-23.94M-30.56M
Net Cash Flow (Quarter)
-83.53M-8.86M105.75M2.50M-25.89M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M